This exclusive session offers pharma leaders a unique opportunity to engage directly with Foundation Medicine and each other in a focused networking environment. Building on the day’s discussions, the engager will spark conversation on the evolving role of liquid biopsy in oncology and provide a platform to explore future partnerships, collaborations and strategic priorities.

Please note: Attendance at this session is subject to availability and partner approval